These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8809813)

  • 1. Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms.
    Ferraro L; O'Connor WT; Li XM; Rimondini R; Beani L; Ungerstedt U; Fuxe K; Tanganelli S
    Neuroscience; 1996 Aug; 73(4):941-50. PubMed ID: 8809813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional neuroanatomy of the ventral striopallidal GABA pathway. New sites of intervention in the treatment of schizophrenia.
    O'Connor WT
    J Neurosci Methods; 2001 Aug; 109(1):31-9. PubMed ID: 11489297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
    Lanza M; Makovec F
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):33-8. PubMed ID: 10651144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a nucleus accumbens CCK2 receptor regulation of rat ventral pallidal GABA levels: a dual probe microdialysis study.
    Ferraro L; O'Connor WT; Glennon J; Tomasini MC; Bebe BW; Tanganelli S; Antonelli T
    Life Sci; 2000 Dec; 68(5):483-96. PubMed ID: 11197746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study.
    Li XM; Ferraro L; Tanganelli S; O'Connor WT; Hasselrot U; Ungerstedt U; Fuxe K
    J Neural Transm Gen Sect; 1995; 102(2):125-37. PubMed ID: 8748677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
    You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
    Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens.
    Tanganelli S; O'Connor WT; Ferraro L; Bianchi C; Beani L; Ungerstedt U; Fuxe K
    Neuroscience; 1994 Jun; 60(3):649-57. PubMed ID: 7936192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through gamma-aminobutyric acid and gamma-aminobutyric acid type B receptors.
    Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
    J Neurosci Res; 2005 Feb; 79(3):412-20. PubMed ID: 15605383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal dopamine D2 receptors in rat forebrain sections.
    Li XM; Hedlund PB; Fuxe K
    Eur J Neurosci; 1995 May; 7(5):962-71. PubMed ID: 7613631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The secretory trypsin inhibitor like-peptide, PEC-60 increases dopamine D2 receptor agonist induced inhibition of GABA release in the dorsolateral neostriatum of the awake freely moving rat. An in vivo microdialysis study.
    Rimondini R; O'Connor WT; Sillard R; Mutt V; Ungerstedt U; Fuxe K
    Regul Pept; 1996 Feb; 61(2):111-7. PubMed ID: 8852813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo neurochemical evidence that newly synthesised GABA activates GABA(B), but not GABA(A), receptors on dopaminergic nerve endings in the nucleus accumbens of freely moving rats.
    Saigusa T; Aono Y; Sekino R; Uchida T; Takada K; Oi Y; Koshikawa N; Cools AR
    Neuropharmacology; 2012 Feb; 62(2):907-13. PubMed ID: 21964521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine reduces dopamine and increases GABA in the nucleus accumbens: an in vivo microdialysis study.
    Murai T; Yoshida Y; Koide S; Takada K; Misaki T; Koshikawa N; Cools AR
    Pharmacol Biochem Behav; 1998 Jul; 60(3):695-701. PubMed ID: 9678653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat.
    Ferraro L; O'Connor WT; Antonelli T; Fuxe K; Tanganelli S
    Eur J Neurosci; 1997 Sep; 9(9):1838-46. PubMed ID: 9383206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area.
    Rahman S; McBride WJ
    J Neurochem; 2002 Feb; 80(4):646-54. PubMed ID: 11841572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel δ1-receptor agonist KNT-127 increases the release of dopamine and L-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex.
    Tanahashi S; Ueda Y; Nakajima A; Yamamura S; Nagase H; Okada M
    Neuropharmacology; 2012 Apr; 62(5-6):2057-67. PubMed ID: 22266218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism.
    Ferraro L; Tanganelli S; O'Connor WT; Antonelli T; Rambert F; Fuxe K
    Eur J Pharmacol; 1996 Jun; 306(1-3):33-9. PubMed ID: 8813612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
    Marshall FH; Barnes S; Pinnock RD; Hughes J
    Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis.
    Yan Q
    Eur J Pharmacol; 1999 Nov; 385(1):7-13. PubMed ID: 10594339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
    Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
    Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.